Sponsor hub
Vanderbilt University clinical trial failures
Review 28 stopped clinical trials from Vanderbilt University, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 22
- OTHER/UNKNOWN
- 6
Notable sponsors
- Vanderbilt University
- 28
Related phases
- Phase I
- 10
- Phase IV
- 7
- Unknown
- 6
- Phase II
- 2
- Phase III
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 28 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Coronary Artery Disease trial by Vanderbilt University. Stop reason: OPERATIONAL.
poor enrollment
Phase I Hypertension trial by Vanderbilt University. Stop reason: OPERATIONAL.
We were not able to enroll adequate number of participants that met the inclusion/exclusion criteria, and we run out of funding.
Phase I Atrial Fibrillation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Study halted/terminated prematurely due to COVID.
Phase II Autonomic Nervous System Diseases trial by Vanderbilt University. Stop reason: OPERATIONAL.
1\. enrollment slower than anticipated; 2. FDA approval of droxidopa so no longer need to treat patients on research basis; 3. personnel who were primarily responsible for the study are no longer at Vanderbilt.
Phase I Hypertension trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
No participants were enrolled
Early Phase I Shy-Drager Syndrome trial by Vanderbilt University. Stop reason: OPERATIONAL.
funding terminated
Phase IV Acute Kidney Injury trial by Vanderbilt University. Stop reason: OPERATIONAL.
lack of recruitment
Phase I Sickle Cell Disease trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
Key personnel moved to new location. Therefore, we had insufficient resources to initiate the trial.
Phase I Hypertension trial by Vanderbilt University. Stop reason: OPERATIONAL.
Could not enroll enough participants, and lost funding.
Phase I Inflammation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Not enough volunteer recruited before funding could be secured.
Phase IV Peripheral Artery Disease trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
We could not secure adequate medication
Phase IV Metabolic Syndrome X trial by Vanderbilt University. Stop reason: OPERATIONAL.
Lack of enrollment
Unknown Obesity trial by Vanderbilt University. Stop reason: OPERATIONAL.
Lack of enrollment due to strict inclusion/exclusion criteria. Bradykinin shortage
Phase III Traumatic Brain Injury trial by Vanderbilt University. Stop reason: OPERATIONAL.
unable to meet recruitment goals
Phase II Congenital Heart Disease trial by Vanderbilt University. Stop reason: OPERATIONAL.
poor enrollment
Phase IV Impaired Glucose Tolerance trial by Vanderbilt University. Stop reason: OPERATIONAL.
Aim 1 was stopped by DSMB. Aim 2 was stopped due to ending of funding.
Phase IV Platelet Aggregation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Funding issue
Unknown Heart Transplantation trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
Unable to perform study due to unavailable drug, then unable to partner with cath lab
Phase IV Human Immunodeficiency Virus Infection trial by Vanderbilt University. Stop reason: OPERATIONAL.
This study was terminated after 6 patients due to loss of funding
Phase I Inflammation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Difficulty recruiting
Phase I Inflammation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Due to lack of funding
Phase IV Depression trial by Vanderbilt University. Stop reason: OPERATIONAL.
Enrollment difficulties
Unknown Heart Transplantation trial by Vanderbilt University. Stop reason: OPERATIONAL.
Bradykinin Shortage, SCCOR expired prior to BK availability, lack of enrollment.
Phase III Oxidative Stress trial by Vanderbilt University. Stop reason: OPERATIONAL.
insufficient enrollment and retention
Phase I Angioneurotic Edema trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
This study was stopped to allow initiation of a mult-center study
Unknown Acute Myocardial Infarction trial by Vanderbilt University. Stop reason: OPERATIONAL.
Funding issue
Unknown Platelet Aggregation trial by Vanderbilt University. Stop reason: OPERATIONAL.
funding issue
Unknown Pain Control trial by Vanderbilt University. Stop reason: OTHER/UNKNOWN.
PI was unable to locate appropriate population